Deciphering the transcription factor-microRNA-target gene regulatory network associated with graphene oxide

Masoumeh Farahani1, Mostafa Rezaei-Tavirani2, Hakimeh Zali3

  • 1a Faculty of Paramedical Sciences , Shahid Beheshti University of Medical Sciences , Tehran , Iran.

Nanotoxicology
|October 17, 2018
PubMed

Insights

Graphene oxide (GO) shows promise in cancer therapy by affecting microRNAs (miRNAs) and genes. This study reveals how GO-induced cytotoxicity involves regulatory networks and pathways crucial for cancer treatment.

Area of Science:

  • Biomedical Engineering
  • Nanotechnology
  • Molecular Biology

Background:

  • Graphene oxide (GO) is a novel material with potential applications in cancer therapy.
  • Understanding the molecular mechanisms of GO's effects on cancer cells is crucial for its therapeutic development.

Purpose of the Study:

  • To investigate the roles of microRNAs (miRNAs) and their target genes in graphene oxide (GO) induced cytotoxicity.
  • To explore the regulatory network involving miRNAs, target genes, and transcription factors (TFs) in GO-treated cancer cells.

Main Methods:

  • Compiled GO-related miRNA and gene data from public databases and literature.
  • Constructed a gene regulatory network including GO-responsive miRNAs, genes, and TFs.
  • Identified and analyzed miRNA-feed-forward loops (FFLs) and associated pathways.

Main Results:

  • A significant gene regulatory network was constructed, highlighting miRNA-FFLs as key motifs.
  • Pathway analysis revealed that adherens junction, focal adhesion, and TGFβ signaling pathways are prominently affected.
  • miRNAs were found to potentially regulate apoptosis by disrupting cell adhesion and targeting cytoskeleton-related genes like Rac1 and RhoA.

Conclusions:

  • Graphene oxide exerts cytotoxicity through complex regulatory networks involving miRNAs and TFs.
  • GO-induced cellular effects impact critical pathways related to cell adhesion and cytoskeleton organization.
  • These findings support the biomedical applications of GO in cancer therapy.

Related Concept Videos

Transcription Factors02:16

Transcription Factors

Tissue-specific transcription factors contribute to diverse cellular functions in mammals. For example, the gene for beta globin, a major component of hemoglobin, is present in all cells of the body. However, it is only expressed in red blood cells because the transcription factors that can bind to the promoter sequences of the beta globin gene are only expressed in these cells. Tissue-specific transcription factors also ensure that mutations in these factors may impair only the function of...
82.7K
Transcription Elongation Factors02:35

Transcription Elongation Factors

Transcription elongation is a dynamic process that alters depending upon the sequence heterogeneity of the DNA being transcribed. Hence, it is not surprising that the elongation complex's composition also varies along the way while transcribing a gene.
The transcription elongation is regulated via pausing of RNA polymerase on several occasions during transcription. In bacteria, these halts are necessary because the transcription of DNA into mRNA is coupled to the translation of that mRNA...
13.9K
Transcription Elongation Factors02:35

Transcription Elongation Factors

4.8K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.2K
Cis-regulatory Sequences02:02

Cis-regulatory Sequences

Cis-regulatory sequences are short fragments of non-coding DNA that are present on the same chromosomes as the genes that they regulate. These fragments serve as binding sites for transcriptional regulators, proteins that are responsible for controlling gene transcription and differential gene expression across cell types in eukaryotes. Cis-regulatory sequences can be close to the gene of interest or thousands of bases away in the DNA sequence; however, those sequences that are further away are...
11.8K
General Transcription Factors01:30

General Transcription Factors

Tissue-specific transcription factors contribute to diverse cellular functions in mammals. For example, the gene for beta globin, a major component of hemoglobin, is present in all cells of the body. However, it is only expressed in red blood cells because the transcription factors that can bind to the promoter sequences of the beta globin gene are only expressed in these cells. Tissue-specific transcription factors also ensure that mutations in these factors may impair only the function of...
7.1K